Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 65 | 31 | 4 | 29 | 71 |
| Gross Profit | 65 | 31 | 4 | 29 | 71 |
| Operating Expenses | 3,181 | 5,810 | 4,686 | 4,639 | 4,700 |
| Operating Income | -3,117 | -5,779 | -4,682 | -4,610 | -4,629 |
| Interest Expense | -96 | -18 | -116 | 29 | 47 |
| Other Income | -2,689 | -1,412 | 218 | -17 | 0 |
| Pre-tax Income | -5,709 | -7,173 | -4,348 | -4,656 | -4,675 |
| Net Income Continuous | -5,709 | -7,173 | -4,348 | -4,656 | -4,675 |
| Net Income | $-5,709 | $-7,173 | $-4,348 | $-4,656 | $-4,675 |
| EPS Basic Total Ops | -1.47 | -1.93 | -1.18 | -1.28 | -1.28 |
| EPS Basic Continuous Ops | -1.47 | -1.93 | -1.18 | -1.28 | -1.29 |
| EPS Diluted Total Ops | -1.47 | -1.93 | -1.18 | -1.28 | -1.28 |
| EPS Diluted Continuous Ops | -1.47 | -1.93 | -1.18 | -1.28 | -1.29 |
| EBITDA(a) | $-3,075 | $-5,740 | $-4,650 | $-4,579 | $-4,597 |